XML 83 R66.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 6,822 $ 14,991
2018 Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 63 13
2018 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 948 968
2018 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 4,455 12,691
2018 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 296 187
PAVmed Inc 2014 Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 37 3
PAVmed Inc 2014 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 463 654
PAVmed Inc 2014 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 173 262
PAVmed Inc 2014 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 387 $ 213